Advancing Oncology Care Quality in the Era of Immuno-Oncology and Other Evolving Treatments
Summary
In June 2016, Avalere in collaboration with the American Society of Clinical Oncology, Cancer Support Community, Community Oncology Alliance, and Patient Advocate Foundation, and with support from Bristol-Myers Squibb, brought together a variety of healthcare stakeholders in a national Dialogue to discuss challenges and opportunities surrounding the advancement of quality in cancer care.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
The objectives of the Dialogue were three-fold:
- Gain consensus on gaps in current cancer and the need for advancing cancer care in the era of immuno-oncology and other emerging treatments
- Discuss potential quality measure topics and what may be prioritized
- Determine a set of consensus-based recommendations to advance quality of care
Download the full report for the findings.
2025: Opportunity Through Uncertainty
Sign Up for Our 2025 Healthcare Industry Outlook Webinar
Register Now
January 23, 11 AM ET
Learn MoreServices
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.
